A
$ Value
$0
Shares
16,200
Price
$0
Filed
Dec 5
Insider
Name
Quigley David
Title
—
CIK
0002098754
Roles
Director
Transaction Details
Transaction Date
2025-10-27
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
16,200
Footnotes
Shares granted pursuant to the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's appointment to the Issuer's board of directors. Award vests in equal monthly installments over thirty-six (36) months on the last day of each month commencing October 31, 2025.
Filing Info
Quigley David's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-10-27 | CRVO | A | $0 |
Other Insiders at CRVO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
ALAM JOHN J
CEO & President
|
— | — | 2026-02-11 |
| Gregoire Sylvie | — | — | 2026-02-11 |
|
Blackburn Kelly
EVP, Clinical Development
|
— | — | 2026-02-11 |
|
ELDER WILLIAM ROBERT
CFO, GC & Secretary
|
— | — | 2026-02-11 |
|
De Rosch Mark
EVP, RA and GA and PgM
|
— | — | 2026-02-11 |
|
Winton Matthew
Chief Commercial and Business
|
— | — | 2026-02-11 |